Loading…
Sat Kartar Life (SATKARTAR)₹155.05+4.62%Pharmaceuticals
In the Sep 2026 quarter (consolidated), Sat Kartar Life reported sales of ₹114 Cr, up 26.7% from Sep 2025, and net profit of ₹9.03 Cr, up 28.4% year on year. For the year to Mar 2026, sales were ₹201 Cr and net profit ₹17.06 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|
| Sales | 87.09 | 90.17 | 111 | 114 |
| Expenses | 79.03 | 80.03 | 96.07 | 99.11 |
| Operating Profit | 8.99 | 9.98 | 14.99 | 14.98 |
| OPM % | 10.0% | 11.0% | 13.0% | 13.0% |
| Other Income | 0.99 | 1.99 | 0.99 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.01 | 1.99 | 2.01 |
| Profit before tax | 7.99 | 9.99 | 12.99 | 11.99 |
| Tax % | 25.0% | 28.1% | 25.1% | 25.1% |
| Net Profit | 6.02 | 7.03 | 10.03 | 9.03 |
| EPS (Rs) | 3.81 | 4.65 | 6.24 | 5.88 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 163 | 201 |
| Expenses | 149 | 176 |
| Operating Profit | 13.98 | 24.99 |
| OPM % | 9.0% | 12.0% |
| Other Income | 0.99 | 1.99 |
| Interest | 1.01 | 1.01 |
| Depreciation | 1.01 | 2.99 |
| Profit before tax | 12.99 | 22.99 |
| Tax % | 25.0% | 26.1% |
| Exceptional items | 0.00 | 1.01 |
| Net Profit | 10.03 | 17.06 |
| EPS (Rs) | 6.26 | 10.89 |
| Dividend payout % | 10.9% | 6.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 15.97 | 15.95 |
| Reserves | 36.02 | 51.99 |
| Borrowings | 6.00 | 1.99 |
| Other Liabilities | 7.03 | 15.05 |
| Total Liabilities | 65.02 | 84.98 |
| Fixed Assets | 5.99 | 12.01 |
| CWIP | 0.00 | 0.99 |
| Investments | 0.00 | 0.00 |
| Other Assets | 58.03 | 71.98 |
| Inventories | 4.55 | 10.46 |
| Trade receivables | 5.99 | 14.50 |
| Cash & equivalents | 30.73 | 21.88 |
| Total Assets | 65.02 | 84.98 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | −5.01 | 0.00 |
| Cash from investing activity | 0.00 | −9.02 |
| Cash from financing activity | 34.05 | −1.01 |
| Net cash flow | 28.03 | −9.02 |
| Capex | 5.19 | 10.17 |
| Free cash flow | −9.97 | −6.97 |
| CFO / OP % | −13.1% | 26.9% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 13 | 26 |
| Inventory days | 184 | 263 |
| Days payable | 170 | 298 |
| Cash conversion cycle | 29 | −7 |
| Working capital days | 31 | 58 |
| ROCE % | — | 36.0% |
For the Sep 2026 quarter, Sat Kartar Life reported sales of ₹114 Cr, up 26.7% year on year and net profit of ₹9.03 Cr, up 28.4% year on year. The operating margin was 13.0%.
Sat Kartar Life's sales for the year to Mar 2026 were ₹201 Cr.
Net profit for the year to Mar 2026 was ₹17.06 Cr. Earnings per share over the same trailing period were ₹10.89.
Sat Kartar Life reported borrowings of ₹1.99 Cr at Mar 2026, against cash and equivalents of ₹21.88 Cr.
Cash from operations was ₹0 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹6.97 Cr.